![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C12N 9/74 | |
C07K 7/00 | |||
C12Q 1/56 | |||
A61K 38/43 |
(11) | Number of the document | 3062813 |
(13) | Kind of document | T |
(96) | European patent application number | 14805360.6 |
Date of filing the European patent application | 2014-10-21 | |
(97) | Date of publication of the European application | 2016-09-07 |
(45) | Date of publication and mention of the grant of the patent | 2020-12-23 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IL2014/000056 |
Date | 2014-10-21 |
(87) | Number | WO 2015/063753 |
Date | 2015-05-07 |
(30) | Number | Date | Country code |
22913413 | 2013-10-29 | IL | |
201361896674 P | 2013-10-29 | US |
(72) |
ORR, Nadav, IL
PILPEL, Yair, IL
DORON, Sivan, IL
|
(73) |
Omrix Biopharmaceuticals Ltd.,
Bldg.14 Weizmann Science Park P.O. Box 619, Rehovot 7610601,
IL
|
(54) | COMPOUNDS AND METHODS FOR STABILIZING THROMBIN ACTIVITY |
COMPOUNDS AND METHODS FOR STABILIZING THROMBIN ACTIVITY |